Potassium Phosphates
NDC 69097-055, Potassium Phosphates, injection, from Cipla USA Inc..
- Product NDC
- 69097-055
- Status
- Listed
- Labeler
- Cipla USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217892
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69097-055 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MONOBASIC POTASSIUM PHOSPHATE224 mg/mL
- DIBASIC POTASSIUM PHOSPHATE236 mg/mL
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69097-055-97 | 69097005597 | 25 VIAL in 1 CARTON (69097-055-97) / 50 mL in 1 VIAL (69097-055-67) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f1f26a17-d2e2-48f5-9054-8ee7e380556e
Use it
Look up 69097-055 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69097-055 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69097-055. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.